Analyst Ratings for Myriad Genetics (MYGN)

MYGN Rating Summary

MYGN Price Target Summary

* Over Last 12-Mos
  |   Expand Research on MYGN
Overall Rating: NEUTRAL   Rating Trend: =   Avg. $ Target: $36.10 (-7%) * Over Last 12-Mos
Rating Score: 3.1 / 10   Percentile Rank: 26%
Date Firm Type Rating
(Past)
PT
(Past)
Start $ End $ % Chg. Details
8/25/2015 Wells Fargo Upgrade Outperform
(Market Perform)
N/A
(N/A)
31.41 38.82 23.59% Details
3/26/2015 Goldman Sachs Downgrade Sell
(Neutral)
25.00
(31.00)
36.20 38.82 7.24% Details
Like MYGN Ratings? Also take a look at AZN, DGX, ILMN, TSRO

MYGN Ratings News